Aplastic anemia with concurrent temozolomide treatment in a patient with glioblastoma multiforme

Temozolomide (tmz) is an oral alkylating agent used during concurrent and adjuvant chemotherapy for newly diagnosed glioblastoma multiforme. Temozolomide is generally well tolerated and improves survival; however, severe adverse events have occasionally been reported. Here, we report the case of a p...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Oh, J., Kutas, G.J., Davey, P., Morrison, M., Perry, J.R.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Multimed Inc. 2010
Ämnen:
Case Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2913822/
https://ncbi.nlm.nih.gov/pubmed/20697524
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk